In the BioHarmony Drug Report Database

"Preview" Icon

Benztropine

Cogentin (benztropine) is a small molecule pharmaceutical. Benztropine was first approved as Cogentin on 1982-01-01. It is used to treat drug-induced abnormalities and parkinson disease in the USA. It is known to target muscarinic acetylcholine receptor M2, muscarinic acetylcholine receptor M1, sodium-dependent dopamine transporter, and sodium-dependent neutral amino acid transporter B(0)AT1.

 

Trade Name

 

Cogentin
 

Common Name

 

benztropine
 

ChEMBL ID

 

CHEMBL1201203
 

Indication

 

drug-induced abnormalities, parkinson disease
 

Drug Class

 

Atropine derivatives

Image (chem structure or protein)

Benztropine structure rendering